Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct 1;27(5):446-453.
doi: 10.1097/MOT.0000000000001003. Epub 2022 Jul 15.

Normothermic machine perfusion of kidneys: current strategies and future perspectives

Franka Messner  1 , Christina Bogensperger  1 , James P Hunter  2   3 , Moritz J Kaths  4 , Cyril Moers  5 , Annemarie Weissenbacher  1
Affiliations
Review

Normothermic machine perfusion of kidneys: current strategies and future perspectives

Franka Messner et al. Curr Opin Organ Transplant. .

Abstract

Purpose of review: This review aims to summarize the latest original preclinical and clinical articles in the setting of normothermic machine perfusion (NMP) of kidney grafts.

Recent findings: Kidney NMP can be safely translated into the clinical routine and there is increasing evidence that NMP may be beneficial in graft preservation especially in marginal kidney grafts. Due to the near-physiological state during NMP, this technology may be used as an ex-vivo organ assessment and treatment platform. There are reports on the application of mesenchymal stromal/stem cells, multipotent adult progenitor cells and microRNA during kidney NMP, with first data indicating that these therapies indeed lead to a decrease in inflammatory response and kidney injury. Together with the demonstrated possibility of prolonged ex-vivo perfusion without significant graft damage, NMP could not only be used as a tool to perform preimplant graft assessment. Some evidence exists that it truly has the potential to be a platform to treat and repair injured kidney grafts, thereby significantly reducing the number of declined organs.

Summary: Kidney NMP is feasible and can potentially increase the donor pool not only by preimplant graft assessment, but also by ex-vivo graft treatment.

PubMed Disclaimer

References

    1. Organ Procurement and Transplantation Network (OPTN): national data reports. Published 2022. https://optn.transplant.hrsa.gov/data/view-data-reports/national-data/ . [Accessed 17 April 2022]
    1. Yearly Statistics Overview Eurotransplant, 2021. Published 2021. https://statistics.eurotransplant.org/index.php?search_type=transplants+... [Accessed 17 April 2022]
    1. Gill J, Rose C, Lesage J, et al. Use and outcomes of kidneys from donation after circulatory death donors in the United States. J Am Soc Nephrol 2017; 28:3647–3657.
    1. Pascual J, Zamora J, Pirsch JD. A systematic review of kidney transplantation from expanded criteria donors. Am J Kidney Dis 2008; 52:553–586.
    1. de Kok MJC, Schaapherder AFM, Alwayn IPJ, et al. Improving outcomes for donation after circulatory death kidney transplantation: Science of the times. PLoS One 2020; 15:e0236662.